Literature DB >> 21683298

Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients.

Arun Raghav Mahankali Sridhar1, Sravanthi Parasa, Udayakumar Navaneethan, Michael D Crowell, Kevin Olden.   

Abstract

BACKGROUND: The full extent of cardiovascular morbidity in inflammatory bowel disease is not well understood.
OBJECTIVE: To comprehensively study the association of different cardiovascular diseases in hospitalized patients with inflammatory bowel disease (IBD) using a large database.
METHODS: We used the Nationwide Inpatient Sample (NIS) database to perform a cross-sectional study. The study group was defined as all hospitalized patients between ages 18-60 years included in the NIS 2006 database with a discharge diagnosis of IBD, as per the International Classification of Diseases - Clinical Modification, 9th revision (ICD-9-CM) codes. Individuals in the same age group whose hospital discharge records did not note IBD were identified as the control group. Cardiovascular diseases, identified by the ICD-9-CM codes, were studied comprehensively for their association with IBD using multivariate logistic regression analysis. Odds ratios were calculated adjusting for relevant patient comorbidities.
RESULTS: IBD was found to be strongly associated with mesenteric ischemia (adjusted odds ratio (aOR), 3.4; 95% confidence interval (CI), 2.9-4.0) and venous thrombotic diseases (aOR, 1.38; 95% CI, 1.25-1.53). Age and gender stratified analysis revealed that IBD is positively associated with dysrhythmias in females aged 18-39 years (aOR, 2.05; 95% CI, 1.72-2.44). We did not find an increased risk of other cardiovascular diseases in IBD patients.
CONCLUSIONS: Our study substantiates the previously reported associations of mesenteric ischemia and venous thrombotic disorders with IBD. Our study also suggests that young females with IBD might have an increased risk for dysrhythmias.
Copyright © 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21683298     DOI: 10.1016/j.crohns.2011.01.011

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  21 in total

Review 1.  Cardiovascular complications in inflammatory bowel disease.

Authors:  Rudolf Schicho; Gunther Marsche; Martin Storr
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Preclinical atherosclerosis in patients with inflammatory bowel diseases: a case-control study.

Authors:  Vincenzo Bruzzese; Giuseppe Palermo; Lorenzo Ridola; Roberto Lorenzetti; Cesare Hassan; Annamaria Izzo; Angelo Zullo
Journal:  Ann Transl Med       Date:  2017-04

Review 3.  Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Authors:  María Rojas-Feria; Manuel Castro; Emilio Suárez; Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 4.  Risk of cardiovascular disease in inflammatory bowel disease.

Authors:  Nynne Nyboe Andersen; Tine Jess
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

5.  Steroid exposure, acute coronary syndrome, and inflammatory bowel disease: insights into the inflammatory milieu.

Authors:  Pearl Zakroysky; Wai-Ee Thai; Roderick C Deaño; Sandeep Basnet; Zurine Galvan Onandia; Sachin Gandhi; Ahmed Tawakol; James K Min; Quynh A Truong
Journal:  Am J Med       Date:  2014-11-13       Impact factor: 4.965

Review 6.  Inflammatory bowel disease and thromboembolism.

Authors:  Petros Zezos; Georgios Kouklakis; Fred Saibil
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 7.  Venous thrombosis and prothrombotic factors in inflammatory bowel disease.

Authors:  Fernando Magro; João-Bruno Soares; Dália Fernandes
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database.

Authors:  Edward L Barnes; Renee M Beery; Allison R Schulman; Ellen P McCarthy; Joshua R Korzenik; Rachel W Winter
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

Review 9.  Enteropathic spondyloarthritis: from diagnosis to treatment.

Authors:  Rosario Peluso; Matteo Nicola Dario Di Minno; Salvatore Iervolino; Francesco Manguso; Giuseppina Tramontano; Pasquale Ambrosino; Carmela Esposito; Antonella Scalera; Fabiana Castiglione; Raffaele Scarpa
Journal:  Clin Dev Immunol       Date:  2013-04-15

10.  Metabolomic profiles are gender, disease and time specific in the interleukin-10 gene-deficient mouse model of inflammatory bowel disease.

Authors:  Victor K Tso; Beate C Sydora; Rae R Foshaug; Thomas A Churchill; Jason Doyle; Carolyn M Slupsky; Richard N Fedorak
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.